论文部分内容阅读
目的:分析奥扎格雷联合参麦注射液治疗脑梗塞疗效。方法:选取本院在2013年1月~2014年12月间收治的200例急性脑梗塞患者。根据入院顺序分为实验组和对照组,每组各100人。对照组患者采用传统的血塞通和低分子右旋糖酐治疗。对实验组患者采用奥扎格雷联合参麦注射液方法进行治疗。两组都进行脑部保护治疗和伴随疾病治疗。结果:经过治疗,实验组患者的显效率为65%,有效率为22%,无效率为13%,治愈率达87%。对照组患者的显效率为44%,有效率为16%,无效率为40%,治愈率为60%。两组间的差异具有统计学意义(P<0.05)。结论:奥扎格雷联合参麦注射液治疗脑梗塞具有较好的疗效,在临床上值得推广应用。
Objective: To analyze the curative effect of ozagrel and shenmai injection on cerebral infarction. Methods: A total of 200 acute cerebral infarction patients admitted to our hospital from January 2013 to December 2014 were selected. According to admission order is divided into experimental group and control group, each group of 100 people. Patients in the control group were treated with conventional Xuesaitong and low molecular weight dextran. Ozagrel combined with Shenmai injection was used to treat the experimental group. Both groups received brain protection and concomitant disease treatment. Results: After treatment, the effective rate of the experimental group was 65%, the effective rate was 22%, the inefficiency rate was 13%, and the cure rate was 87%. In the control group, the effective rate was 44%, the effective rate was 16%, the inefficiency rate was 40% and the cure rate was 60%. The difference between the two groups was statistically significant (P <0.05). Conclusion: Ozagrel combined with Shenmai injection in the treatment of cerebral infarction has a good curative effect, which is worthy of popularization and application in clinic.